Clinical Trials Directory

Trials / Unknown

UnknownNCT05302726

Impact of Exogenous Estrogens on Cotisol Levels During Synacthen Stimulation

Betydning af Eksogent østrogen på Serum Kortisol Under Synacthen-stimulering Hos Hypogonade Kvinder Med Binyrebarkinsufficiens

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The aim is to investigate impact of exogenous estrogens on cotisol Levels during synacthen stimulation in female hypogonal patients on estrogen substitution. Both patients with and withour adrenal insufficiency will be studied

Detailed description

The aim is to investigate impact of exogenous estrogens on cotisol levels during synacthen stimulation in female hypogonal patients on estrogen substitution. Both patients with and without adrenal insufficiency will be studied . All patients (inclusion criteria age 18-50 years, BMI \<35) will be followed for 6 months and have 3 synacthentests performed: One on transdermal estrogen (minimum 3 months), one on oral estrogens (min 3 months) and one without estrogen substitution for at least 3 months. Primary endpoint is change in serum cortisol 30 minutes after synacthen stimulation

Conditions

Interventions

TypeNameDescription
DRUGEstrogenTransdermal and oral estrogen both as substitution therapy

Timeline

Start date
2022-01-01
Primary completion
2022-12-31
Completion
2023-06-01
First posted
2022-03-31
Last updated
2022-03-31

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05302726. Inclusion in this directory is not an endorsement.